DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 171 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $13,452,000 | -21.4% | 300,000 | 0.0% | 0.07% | -35.0% |
Q4 2020 | $17,121,000 | +1.1% | 300,000 | -9.1% | 0.10% | -12.0% |
Q3 2020 | $16,929,000 | -60.4% | 330,000 | -53.8% | 0.12% | -65.8% |
Q2 2020 | $42,700,000 | +3.7% | 715,000 | -28.5% | 0.34% | -3.1% |
Q1 2020 | $41,170,000 | -30.4% | 1,000,000 | +5.3% | 0.35% | -11.5% |
Q4 2019 | $59,128,000 | +132.3% | 950,000 | +26.7% | 0.40% | +107.8% |
Q3 2019 | $25,455,000 | +1240.4% | 750,000 | +650.0% | 0.19% | +1029.4% |
Q3 2017 | $1,899,000 | – | 100,000 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |